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1. INTRODUCTION 
Interaction of ethanol with essential fatty acid 
(EFA) metabolism has been demonstrated in man 
[ 1,2] and in experimental animals [3,4]. Several 
laboratories have reported on the effects of 
ethanol on changed proportions of poly- 
unsaturated fatty acids in cell membranes [5,6,7]. 
In a series of experiments with ethanol and EFA 
we found increased concentrations of 
phospholipids in the brain of rats after 3 weeks of 
ethanol administration (3 g/kg body weight, daily 
intraperitoneal injections). This phospholipid in- 
crease was due to an increase of the acidic fraction 
of the phospholipids [4]. Examination of the pro- 
portions of individual neutral and acidic lipids by 
thin-layer chromatography (TLC) revealed the oc- 
currence of an abnormal lipid fraction in organs 
from rats exposed to ethanol. This article is a 
report on the appearance of this abnormal lipid in 
various organs and the relation to the amount and 
duration of ethanol administration. Our currently 
available information on the chemical structure of 
the lipid is also given. 
2. MATERIALS AND METHODS 
2.1. Animals 
Three different experiments were performed: 
two with different methods of ethanol exposure 
and one focusing on the time course of the ap- 
pearance of the fraction. After the ethanol ad- 
ministration periods, rats were killed by decapita- 
tion and brain, kidney, liver, skeletal muscle and 
serum were taken for analysis. In expt I and II the 
ethanol rats were killed in an intoxicated state. 
In expt I 24 Sprague-Dawley rats (female rats, 
5 weeks old) received diets with either normal or 
low levels of EFA [8]. Ethanol (3 g/kg body 
weight) was given by intraperitoneal injections 
once a day to 12 of the rats (6 from each diet 
group). Each injected resulted in a maximum 
blood ethanol concentration of about 3 mg/ml. 
Isocaloric amounts of glucose were given to the 12 
control animals. The ethanol treatment continued 
for 21 days. 
In expt II, 12 Sprague-Dawley rats received 
ethanol in a semi-synthetic liquid diet. Six control 
animals received isocaloric amounts of sucrose in 
their diets. After 16 days half of the rats in each 
group were killed. The remaining rats were main- 
tained on the liquid diet, all without ethanol, for a 
further 5 days, before they were killed and 
analysed. 
Expt III was a time course test. Twelve 
Sprague-Dawley rats were injected intra- 
peritoneally with ethanol (3 g/kg body weight). 
Two rats each were killed at 1, 2, 4, 8 and 24 h 
after injection. 
2.2. Lipid analyses 
Animals were analysed individually. The lipids 
were extracted from different organs as in [4], and 
the extracts were divided into one neutral, and one 
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acidic fraction on an anionic ion-exchange resin 
[9]. The acidic lipids were separated on TLC and 
HPTLC-plates (Merck, Darmstadt) with the sol- 
vent system chloroform-acetone-methanol-acetic 
acid-water, 5.0: 1.5: 1.5: 1.0:0.5. The chromato- 
grams were stained with Cu(Ac)z-reagent, and 
heated for 20 min at 130°C. The reference lipids 
phosphatidylinositol, phosphatidylserine, phos- 
phatidylglycerol, cardiolipin and phosphatidic acid 
were obtained from Sigma (St Louis MO). Free 
fatty acids were obtained after hydrolysis of corn 
oil. Bis(monoacylglyceryl)phosphate isolated from 
the muscles of chloroquine-intoxicated miniature 
pigs [lo] and sulphatide from human brain were 
donated by Dr Olle Nilsson (Department of 
Psychiatry and Neurochemistry, University of 
Goteborg). For detection of carbohydrates TLC- 
plates were stained with orcinol, and for detection 
of primary amino groups with ninhydrin reagent, 
Fatty acid proportions were determined by gas- 
liquid chromatography (GLC) and quantitative 
determinations of lipid phosphorous were per- 
formed as in [ 111. The percentage composition of 
phospholipids in expt III was assayed with densi- 
tometry (Zeiss KM3 densitometer) after staining of 
the HPTLC-plate with Cu(Ac)z-reagent and heating 
for 20 min at 130°C. In all the other cases the 
determination of lipid phosphorous in individual 
phospholipids was made after isolation by pre- 
parative TLC [ 111. 
3. RESULTS AND DISCUSSION 
3.1. Appearance and organ distribution in relation 
to ethanol exposure 
In rats given ethanol intraperitoneally for 21 
days (expt I) the highest relative concentration of 
the abnormal lipid fraction was found in kidney, 
Skeletal 
mUSCle Liver 
PA 
Fig. 1. HPTLC of the acidic lipids from different organs in rats from expt I. The concentration f the unknown fraction 
(X) varies between these organs, and has the highest concentration i  kidney. Reference lipids were PI, phosphatidyl- 
inositol; PS, phosphatidylserine; sulf, sulphatide; PG, phosphatidylglycerol; card, cardiolipin; PA, phosphatidic acid; 
FFA, free fatty acids. 
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followed by brain, liver and skeletal muscle (fig. 1). 
The concentrations of the total fraction of acidic 
lipids in brain were higher in ethanol-treated rats 
fed both the low EFA and the normal EFA diets 
than in controls. The unknown compound con- 
stituted about 10% of these acidic fractions (table 
1). The compound could not be detected in serum. 
The high concentration in membrane-dense organs 
like kidney and brain and the absence from serum 
Table 1 
Lipid phosphorous in acidic fraction, in expt I 
Brain Kidney 
n M-t S.D. n M? SD. 
pmol/g ww 
0.3 Energy-% EFA 
Controls 6 12.2 + 1.67 6 8.6 k 0.21 
Ethanol 5 12.3 f 1.41 4 10.0 k 0.60 
Unknown fraction 5 1.2kO.15 4 1.4kO.34 
3.0 Energy-% EFA 
Controls 5 12.4+ 1.21 6 8.1 kO.60 
Ethanol 6 13.8 f 1.00 5 10.6 k 0.59 
Unknown fraction 6 1.41t 0.16 5 2.1 kO.36 
*h 2h 
indicated a localization to membrane structures. 
The abnormal fraction developed both in rats with 
low and normal EFA content in their diets. 
These initial findings suggested that the abnor- 
mal fraction was a degradation product in cell 
membranes as a result of the chronic exposure to 
ethanol. Therefore the next animal study (expt II) 
was designed in order to elucidate reversibility. In 
this experiment he blood-ethanol concentration 
varied, due to differences in the voluntary ethanol 
consumption. A relation was found between the 
concentrations of ethanol and of the abnormal 
fraction. Five days after interruption of ethanol 
exposure, the unknown compound could no longer 
be detected. From these results it was obvious that 
the abnormal fraction had a more rapid ap- 
pearance and disappearance than had been initially 
expected. 
In expt III the short-term relationship between 
ethanol and the abnormal fraction was studied. 
The pathological acidic lipid was found in rats for 
1, 2, and 4 h after the ethanol injection but had 
already disappeared at 8 h (fig.2). The concentra- 
tion of the fraction varied during the period from 
l-4 h with a maximum at 2 h after ethanol injec- 
tion, which indicates a slight delay in relation to 
the peak of the blood-ethanol profile (fig.3). 
Ib II #I, 
t . - 
Fig.2. HPTLC of the acidic lipids from kidneys in expt III. This chromatogram shows the appearance and disappear- 
ance of the unknown compound after an injection of ethanol. The compound constituted 10.1, 11.8 and 9.0% of the 
major acidic lipids (phosphatidylinositol, phosphatidylserine, unknown fraction and cardiolipin) in rats 1, 2 and 4 h 
after injection. At 8 and 24 h the compound was undetectable. 
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From these experiments it is concluded that the 
concentration of the observed abnormal acidic 
lipid is strongly related to the blood-ethanol level 
and fully reversible. All analysed organs were af- 
12345678 
hours 
Fig.3. The blood ethanol pofile after an injection of 
3 g/kg body weight in rats not previously treated with 
ethanol. 
fected but not blood serum. This indicates that the 
abnormal lipid does not appear in the tissues after 
formation in for example the liver and subsequent 
blood transport. The formation of the unknown 
lipid therefore takes place within the organs 
themselves. 
3.2. Chromatographic investigations in relation 
to reference compounds 
A series of experiments was performed to estab- 
lish the chemical nature of the abnormal lipid frac- 
tion. The fact that the compound was bound to an 
anionic ion-exchange resin [9] indicates acidic 
properties. A number of acidic lipids available in 
our laboratory were compared with the unknown 
compound for Rr-values in HPTLC (fig.4) but none 
of them proved to be identical. The possibility that 
the substance was one of the intermediates in the 
methylation of phosphatidylethanolamine during 
formation of phosphatidylcholine was also investi- 
gated [12]. This was found not to be the case 
judging from identity in HPTLC, in the solvent 
system chloroform-propionic acid-n-propanol- 
water, 2 : 2 : 3 : 1. 
ethanol 
Fig.4. HPTLC for comparison of &-values of different references and the unknown fraction (X). The references used 
were: PI, phosphatidylinositol; PS, phosphatidylserine; PG, phosphatidylglycerol; card, cardiolipin; BMP, bis(mono- 
acylglyceryl)phosphate; PA, phosphatidic acid; FFA, free fatty acids. 
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Table 2 
Fatty acid composition of the unknown fraction in 
kidney from rats injected intraperitoneally with ethanol 
(expt I) 
Fatty acids 
16:0 
18:O 
18:l 
18 : 2(n-6) 
20 : 3(n-9) 
20 : 4(n-6) 
22 : 6(n-3) 
0.3 Energy-% 3.0 Energy-% 
EFA (n = 6) EFA (n = 6) 
M f S.D. M f S.D. 
21.7 + 1.75 23.5 + 1.03 
11.7 + 1.09 14.8 k 0.51 
33.4 * 1.24 22.3 -I 0.79 
3.5 + 0.20 8.0 t 0.52 
7.6 k 0.63 0.5 * 0.41 
15.0 f 1.47 22.6 -t 0.73 
1.0 + 0.22 2.3 t 0.18 
3.3. Chemical investigations of possible structure 
The chemical characterization of the unknown 
acidic lipid showed that the substance contained 
phosphorous and fatty acids in a molar ratio of 
about 1:2. The fatty acid composition is given in 
table 2. Palmitic (16:0), oleic (18:l) and 
arachidonic acid (20: 4(n-6)) dominated and the 
fatty acid pattern was determined by the diet given 
to the rats. These findings indicate that the struc- 
tural frame of the molecule is probably similar to 
that of phosphoglycerides in general and that at 
least part of the molecule exists prior to ethanol 
administration. 
The abnormal fraction did not react to 
ninhydrin or orcinol reagents on thin-layer plates, 
indicating the absence of primary amino groups 
and carbohydrates. Addition of ethanol to the 
tissue homogenates prior to the lipid extraction did 
not give rise to the observed abnormal compound. 
3.4. Structural considerations 
There are several alternatives for the structure. 
Increased lipid peroxidation after ethanol ad- 
ministration to rats has been reported [13]. 
Phospholipids with peroxidized fatty acids or 
Schiff base-like products attributable to increased 
levels of malondialdehyde also have to be con- 
sidered, since malondialdehyde might give rise to 
condensation products with amino groups of 
phospholipids. 
28 
Another possibility is that the ethanol might 
have inhibited an enzyme responsible for the 
metabolism of phospholipids with accumulation of 
an intermediate, which normally occurs only in 
trace quantities. This is supported by the relatively 
rapid appearance of the substance. An uniden- 
tified reaction between ethanol or acetaldehyde 
and a phospholipid or a phospholipid metabolite is 
also plausible. These possibilities are at present be- 
ing investigated in large scale preparations which 
will be submitted to further structural analysis. 
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